ai-drug-discovery
AI-driven drug discovery applies machine learning and computational modeling to identify and optimize bioactive compounds, accelerating the pipeline from target identification to candidate molecules. In plant science, this approach is particularly valuable for mining the vast chemical diversity of plant secondary metabolites, enabling researchers to predict biological activity, toxicity, and therapeutic potential of phytochemicals far more efficiently than traditional screening methods.
open_in_new WikipediaPubMed · 2026-04-29
Astragalin, a flavonoid found naturally in plants like milkvetch and moringa, was shown to reduce gut inflammation in mice by binding and dismantling a key immune protein (FPR1), while simultaneously restoring beneficial gut bacteria and protective metabolites — suggesting it could become a plant-derived multi-target therapy for inflammatory bowel disease.
A deep-learning platform identified FPR1 as astragalin's primary molecular target; astragalin directly binds FPR1 and accelerates its destruction via the cell's protein-recycling machinery, blocking NF-κB inflammatory signaling
Astragalin treatment significantly enriched the beneficial gut bacterium Akkermansia muciniphila and reversed colitis-associated disruptions in glutathione and L-ascorbate (vitamin C) metabolism
In a mouse colitis model, astragalin reduced pro-inflammatory cytokines, improved intestinal barrier integrity, and ameliorated visible disease symptoms
